M&A is picking up in the European imaging sector this week with Affidea and Naxicap buying big in Italy and Switzerland, respectively, and a top-five German imaging group reportedly in the middle of a sales process.
Outpatient group Gajda-Med has won Poland's multi-million euro contract to deliver first-contact telehealth services for the Polish NHS. It follows a recent trend of private sector companies moving to work on national hotlines, including in Sweden and Switzerland, and it is very controversial where operators already own physical clinics.
Assisted living operators in Switzerland are using the same asset-light business model that is dominant in France and Germany. As HBI continues to grow its HBI Intelligence report on assisted living, we speak to Stefan Buser, who used to work for Swiss nursing home and assisted living operator SENIOcare, to find out why.
Listed Swiss Investment company Aevis Victoria has agreed to buy out the remaining physician shareholders of Zurich-based Klinik Pyramide and integrate it into its hospital subsidiary Swiss Medical Network.
Group revenue fell 3% at South Africa-based EMEA hospital group Mediclinic International for the year ending March 31, 2021. But there were positive signs in H2 as the London-listed group came to terms with how to work during a pandemic, and the group is bullish about next year despite a particularly challenging start to the last.
Executive chairman Jos Lamers has told HBI that Covid sales continue to rise in Q1 and Q2 2021. They certainly boosted 2020 results at the international lab and imaging group owned by Apax Partners. Like rivals Synlab and Sonic, the business continues to roar away.
Private hospital operators across Europe, the Middle East and South Africa had a good last few months of trading in what was a turbulent 2020, but the start of 2021 looks tougher. We talk to operators across the region.
Private equity firm Carlyle will exit German and Swiss acute/psychiatric hospital operator Ameos Group in the second half of this year, a spokesperson for Ameos tells HBI. Reports say that CEO Dr Axel Paeger and London-listed Intermediate Capital Group (ICG) will become controlling shareholders.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
